N-(4,5-DIMETHYL-3-ISOXAZOLYL)-N-(METHOXYMETHYL)-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZENESULFONAMIDE
UNII FFR8SBR34U
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(4,5-dimethyl-3-isoxazolyl)-n-(methoxymethyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FFR8SBR34U.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 415697-56-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H27BN2O6S IJSCQWFSMOZUEJ-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(4,5-dimethyl-3-isoxazolyl)-n-(methoxymethyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.